title: Long-term follow-up of implantable cardioverter defibrillator therapy for hypertrophic cardiomyopathy.
abstract: In this study, high-risk patients with hypertrophic cardiomyopathy were treated with an implantable defibrillator. Long-term follow-up analysis showed the efficacy of implantable defibrillator therapy, with patients having an appropriate device intervention at a rate of 11%/year, thereby preventing sudden death in an Australian population.
authors.affiliation: Agnes Ginges Centre for Molecular Cardiology, Centenary Institute, Newtown, New South Wales, Australia.
authors.forename: Irandi
authors.initials: I
authors.lastname: Jayatilleke
authors.forename: Alessandra
authors.initials: A
authors.lastname: Doolan
authors.forename: Jodie
authors.initials: J
authors.lastname: Ingles
authors.forename: Mark
authors.initials: M
authors.lastname: McGuire
authors.forename: Virginia
authors.initials: V
authors.lastname: Booth
authors.forename: David R
authors.initials: DR
authors.lastname: Richmond
authors.forename: Christopher
authors.initials: C
authors.lastname: Semsarian
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D001315:Australia; D002312:Cardiomyopathy, Hypertrophic / Q000453:epidemiology / Q000628:therapy*; D017147:Defibrillators, Implantable; D005500:Follow-Up Studies; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000453:epidemiology / Q000628:therapy; D008875:Middle Aged; D011183:Postoperative Complications / Q000453:epidemiology / Q000209:etiology; D012307:Risk Factors; D013015:Sotalol / Q000627:therapeutic use; D013995:Time; D016896:Treatment Outcome
chemical_list: D000319:Adrenergic beta-Antagonists; D013015:Sotalol